Genetics of amyotrophic lateral sclerosis

被引:3
作者
Huebers, A. [1 ]
Weishaupt, J. H. [1 ]
Ludolph, A. C. [1 ]
机构
[1] Univ Ulm, Univ Klinikum Ulm, Neurol Klin, D-89081 Ulm, Germany
来源
NERVENARZT | 2013年 / 84卷 / 10期
关键词
Genetics; C9orf72; SOD1; FUS; TDP-43; HEXANUCLEOTIDE REPEAT; MUTATIONS; C9ORF72; DISEASE;
D O I
10.1007/s00115-013-3898-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) is an aggressive rapidly progressing degeneration of both upper and lower motor neurons. Clinically, ALS is characterized by rapidly progressing atrophy and paresis of the muscles of the extremities. The genetics of ALS have become more complex in the last 5 years. The SOD gene is still very important; however, in recent years mutations in the genes for TDP-43 and FUS were discovered and also a most interesting intronic repeat expansion of the hexanucleotide repeat in C9ORF72 has been shown to be the most common in ALS. There are other quantitatively less relevant genes, which, however, are meaningful for pathogenetic aspects. It is also necessary to know that the phenotypes associated with ALS genetics have expanded.
引用
收藏
页码:1213 / +
页数:6
相关论文
共 50 条
[31]   The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia [J].
Abramzon, Yevgeniya A. ;
Fratta, Pietro ;
Traynor, Bryan J. ;
Chia, Ruth .
FRONTIERS IN NEUROSCIENCE, 2020, 14
[32]   Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability? [J].
Talbot, Kevin .
JOURNAL OF ANATOMY, 2014, 224 (01) :45-51
[33]   The role of RNA metabolism in the pathogenesis of amyotrophic lateral sclerosis [J].
Lysogorskaia, E. V. ;
Abramycheva, N. Yu. ;
Illarioshkin, S. N. ;
Zakharova, M. N. .
NEUROCHEMICAL JOURNAL, 2012, 6 (03) :233-238
[34]   Amyotrophic lateral sclerosis [J].
Feldman, Eva L. ;
Goutman, Stephen A. ;
Petri, Susanne ;
Mazzini, Letizia ;
Savelieff, Masha G. ;
Shaw, Pamela J. ;
Sobue, Gen .
LANCET, 2022, 400 (10360) :1363-1380
[35]   Neuronal Death in Amyotrophic Lateral Sclerosis (ALS): What Can We Learn from Genetics? [J].
Sreedharan, J. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (03) :259-267
[36]   Molecular basis of amyotrophic lateral sclerosis [J].
Liscic, Rajka M. ;
Breljak, Davorka .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02) :370-372
[37]   Amyotrophic lateral sclerosis: a clinical review [J].
Masrori, P. ;
Van Damme, P. .
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (10) :1918-1929
[38]   Amyotrophic Lateral Sclerosis: Problems and Prospects [J].
Sreedharan, Jemeen ;
Brown, Robert H., Jr. .
ANNALS OF NEUROLOGY, 2013, 74 (03) :309-316
[39]   Modeling of lateral amyotrophic sclerosis: a non-genetic method [J].
Bachurin, S. O. ;
Ninkina, N. N. ;
Tarasova, T. V. ;
Shelkovnikova, T. V. ;
Kovrazhkina, E. A. ;
Smirnov, A. P. ;
Razinskaya, O. ;
Skvortsova, V. I. .
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (09) :86-88
[40]   Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis [J].
Goutman, Stephen A. ;
Hardiman, Orla ;
Al-Chalabi, Ammar ;
Chio, Adriano ;
Savelieff, Masha G. ;
Kiernan, Matthew C. ;
Feldman, Eva L. .
LANCET NEUROLOGY, 2022, 21 (05) :465-479